Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union

Autor: Kelly H. Zou, Marc L. Berger

Publikováno v: Bioengineering, Vol 11, Iss 8, p 784 (2024)

The use of real-world data (RWD) for healthcare decision-making is complicated by concerns regarding whether RWD is fit-for-purpose or is of sufficient validity to support the creation of credible RWE. An efficient mechanism for screening the quality

Externí odkaz: https://doaj.org/article/ce7bc56917104ff0aaed9dea0a62a0ef

How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers?

Autor: William H. Crown, Marc L. Berger

Publikováno v: Value in Health. 25:167-170

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1711d8b854f5f233f0c61ba24e4dc14a
https://doi.org/10.1016/j.jval.2021.09.002

Identifying the Need for Good Practices in Health Technology Assessment

Autor: Kenneth Bond, Daniel A. Ollendorf, Uwe Siebert, Don Husereau, Egon Jonsson, Finn Børlum Kristensen, Mirjana Huić, Jitendar Sharma, Marc L. Berger, Federico Augustovski, Michael Drummond, Alric Rüther, Maarten Joost IJzerman, John F.P. Bridges, Jeremy M. Grimshaw, Andrew Booth, Allan Wailoo

Publikováno v: Value in health, 22(1), 13-20. Elsevier
Kristensen, F B, Husereau, D, Huić, M, Drummond, M, Berger, M L, Bond, K, Augustovski, F, Booth, A, Bridges, J F P, Grimshaw, J, IJzerman, M J, Jonsson, E, Ollendorf, D A, Rüther, A, Siebert, U, Sharma, J & Wailoo, A 2019, ' Identifying the Need for Good Practices in Health Technology Assessment : Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA ', Value in Health, vol. 22, no. 1, pp. 13-20 . https://doi.org/10.1016/j.jval.2018.08.010

The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe454b38ed1acb6d1a9cc8a1fa65169
http://www.scopus.com/inward/record.url?scp=85058171877&partnerID=8YFLogxK

A Randomized Controlled Open Trial of Population-based Disease and Case Management in a Medicare Plus Choice Health Maintenance Organization

Autor: David C. Martin, Marc L. Berger, David T. Anstatt, Jonathan Wofford, DeAnn Warfel, Robin S. Turpin, Carolyn C. Cannuscio, Steven M. Teutsch, Bernard J. Mansheim

Publikováno v: Preventing Chronic Disease, Vol 1, Iss 4 (2004)

Introduction The object of this study was to examine the effect of population-based disease management and case management on resource use, self-reported health status, and member satisfaction with and retention in a Medicare Plus Choice health maint

Externí odkaz: https://doaj.org/article/df2d5b3d5b9041cdaaec4498d1e5291f

PDG1 Comparative Effectiveness and Safety of Pharmaceuticals Assessed in Observational Studies Compared with Randomized Controlled Trials

Autor: Richard J. Willke, John Guerino, Marc L. Berger, William H. Crown, Wim G. Goettsch, LS Orsini, C.D. Mullins, Jeroen P. Jansen, Y.D. Hong, Gail Betz

Publikováno v: Value in Health. 23:S521

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f61d99effc61f8424081a0ce88caf58
https://doi.org/10.1016/j.jval.2020.08.684